{"id":"https://openalex.org/W2013144286","doi":"https://doi.org/10.1159/000011965","title":"Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study","display_name":"Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W2013144286","doi":"https://doi.org/10.1159/000011965","mag":"2013144286","pmid":"https://pubmed.ncbi.nlm.nih.gov/10202274"},"language":"en","primary_location":{"id":"doi:10.1159/000011965","doi":"https://doi.org/10.1159/000011965","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000011965","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108427383","display_name":"Dimitrios I. Bafaloukos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132093","display_name":"Metaxa Hospital","ror":"https://ror.org/03v7hnv07","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210132093"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"D. Bafaloukos","raw_affiliation_strings":["Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus, Greece","Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus, Greece","institution_ids":["https://openalex.org/I4210132093"]},{"raw_affiliation_string":"Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,","institution_ids":["https://openalex.org/I4210132093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039349296","display_name":"Gerasimos Aravantinos","orcid":"https://orcid.org/0000-0002-2106-1713","observed_orcids":["https://orcid.org/0000-0002-2106-1713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Aravantinos","raw_affiliation_strings":["Third Department of Medical Oncology, Ag. Anargiri Cancer Hospital, Athens,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Medical Oncology, Ag. Anargiri Cancer Hospital, Athens,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010312876","display_name":"George Samonis","orcid":"https://orcid.org/0000-0001-5857-9703","observed_orcids":["https://orcid.org/0000-0001-5857-9703"]},"institutions":[{"id":"https://openalex.org/I142617266","display_name":"University of Crete","ror":"https://ror.org/00dr28g20","country_code":"GR","type":"education","lineage":["https://openalex.org/I142617266"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"G. Samonis","raw_affiliation_strings":["Department of Medical Oncology, University of Crete, Heraklion, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University of Crete, Heraklion, Greece","institution_ids":["https://openalex.org/I142617266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050924116","display_name":"Gikas E. Katsifis","orcid":"https://orcid.org/0000-0002-3214-7416","observed_orcids":["https://orcid.org/0000-0002-3214-7416"]},"institutions":[{"id":"https://openalex.org/I4210132093","display_name":"Metaxa Hospital","ror":"https://ror.org/03v7hnv07","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210132093"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"G. Katsifis","raw_affiliation_strings":["Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,","institution_ids":["https://openalex.org/I4210132093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027874366","display_name":"Charalambos Bakoyiannis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132093","display_name":"Metaxa Hospital","ror":"https://ror.org/03v7hnv07","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210132093"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"C. Bakoyiannis","raw_affiliation_strings":["Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,","institution_ids":["https://openalex.org/I4210132093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108223709","display_name":"Dimosthenis-Vasilios Skarlos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Skarlos","raw_affiliation_strings":["Third Department of Medical Oncology, Ag. Anargiri Cancer Hospital, Athens,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Medical Oncology, Ag. Anargiri Cancer Hospital, Athens,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108599039","display_name":"P. Kosmidis","orcid":"https://orcid.org/0009-0003-1478-0087","observed_orcids":["https://orcid.org/0009-0003-1478-0087"]},"institutions":[{"id":"https://openalex.org/I4210132093","display_name":"Metaxa Hospital","ror":"https://ror.org/03v7hnv07","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210132093"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"P. Kosmidis","raw_affiliation_strings":["Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Medical Oncology, Metaxa's Cancer Hospital of Piraeus,","institution_ids":["https://openalex.org/I4210132093"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.78,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.83482215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"56","issue":"3","first_page":"198","last_page":"201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/recurrent-endometrial-cancer","display_name":"recurrent endometrial cancer","score":0.8970000147819519},{"id":"https://openalex.org/keywords/advanced-endometrial-cancer","display_name":"advanced endometrial cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9490000009536743},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":1.0},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":1.0},{"id":"https://openalex.org/keywords/medroxyprogesterone-acetate","display_name":"medroxyprogesterone acetate","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.675000011920929},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.5630000233650208},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6389999985694885},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5389999747276306},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9290000200271606},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9023504257202148},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.7189568281173706},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6182984113693237},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6027340292930603},{"id":"https://openalex.org/C2776306185","wikidata":"https://www.wikidata.org/wiki/Q2823834","display_name":"Medroxyprogesterone acetate","level":3,"score":0.5801873803138733},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5388118624687195},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.4965711236000061},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47666245698928833},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.46599280834198},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4476546049118042},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4200893044471741},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.398973673582077},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3738517165184021},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22488421201705933},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.12908542156219482},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.09328559041023254}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017258","descriptor_name":"Medroxyprogesterone Acetate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000011965","doi":"https://doi.org/10.1159/000011965","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000011965","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:10202274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10202274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1520854244","https://openalex.org/W1585512747","https://openalex.org/W1981534925","https://openalex.org/W1988275568","https://openalex.org/W2001879130","https://openalex.org/W2011978272","https://openalex.org/W2028269517","https://openalex.org/W2039155094","https://openalex.org/W2049902445","https://openalex.org/W2056503174","https://openalex.org/W2062441683","https://openalex.org/W2064367468","https://openalex.org/W2064411691","https://openalex.org/W2084756409","https://openalex.org/W2139040913","https://openalex.org/W2259917975","https://openalex.org/W2409571874","https://openalex.org/W2410563954","https://openalex.org/W2434048649","https://openalex.org/W3012631797","https://openalex.org/W4238668552"],"related_works":["https://openalex.org/W87237173","https://openalex.org/W2068659150","https://openalex.org/W1968829505","https://openalex.org/W4230796488","https://openalex.org/W171483413","https://openalex.org/W1585512747","https://openalex.org/W2039155094","https://openalex.org/W2519415946","https://openalex.org/W1971819112","https://openalex.org/W2527024269"],"abstract_inverted_index":{"Twenty-three":[0],"patients":[1,61,82,199],"with":[2,37,89,179,194,200],"advanced":[3],"or":[4,128,202],"recurrent":[5,201],"endometrial":[6,204],"carcinoma":[7],"entered":[8],"a":[9,32],"prospective":[10],"study":[11],"of":[12,16,79,184],"chemotherapy":[13,54],"which":[14],"consisted":[15],"carboplatin":[17],"(300":[18],"mg/m2),":[19,22],"methotrexate":[20],"(30":[21],"and":[23,119,132,144,159,171],"5-fluoruracil":[24],"(500":[25],"mg/m2)":[26],"given":[27,139],"on":[28,140],"day":[29],"1,":[30],"in":[31,35,77,116,122,198],"3-weekly":[33],"schedule,":[34],"combination":[36],"medroxyprogesterone":[38],"acetate":[39],"(MPA):":[40],"300":[41],"mg":[42],"daily,":[43],"p.":[44],"o.,":[45],"until":[46],"progression":[47],"(JMF-M":[48],"regimen).":[49],"None":[50],"had":[51,62],"received":[52,63],"prior":[53],"and/or":[55],"hormonotherapy":[56],"for":[57],"metastatic":[58,203],"disease.":[59],"Ten":[60],"radiotherapy.":[64],"Response":[65],"to":[66],"treatment":[67,178],"was":[68,75,99,106,138,145,181],"evaluated":[69],"every":[70],"two":[71],"courses.":[72],"Objective":[73],"response":[74,97],"seen":[76],"17":[78],"the":[80,114,117,120,188],"23":[81],"(74%,":[83],"95%":[84],"confidence":[85],"interval":[86],"=":[87],"52-90%),":[88],"2":[90,111,175],"long-lasting":[91],"complete":[92,112],"responses":[93],"(9%).":[94],"The":[95,103,110,136,148,161],"median":[96,104],"duration":[98],"10+":[100],"months":[101,108],"(3-45+).":[102],"survival":[105],"16+":[107],"(2-45+).":[109],"responders,":[113],"first":[115],"lung":[118],"second":[121],"groin":[123],"nodes,":[124],"are":[125],"without":[126],"evidence":[127],"recurrence":[129],"after":[130],"32":[131],"45":[133],"months,":[134],"respectively.":[135],"regimen":[137,190],"an":[141,195],"outpatient":[142],"basis":[143],"well":[146],"tolerated.":[147],"major":[149],"toxic":[150],"effects":[151,164],"were":[152],"myelosuppression":[153],"(less":[154],"than":[155],"14%":[156],"leukopenia,":[157],"anemia":[158],"thrombocytopenia).":[160],"MPA-related":[162],"side":[163],"were:":[165],"weight":[166],"gain":[167],"(22%),":[168],"hypertension":[169],"(17%)":[170],"thromboplebitis":[172],"(17%).":[173],"In":[174,186],"patients,":[176],"consolidation":[177],"MPA":[180],"discontinued":[182],"because":[183],"thromboplebitis.":[185],"conclusion,":[187],"JMF-M":[189],"is":[191],"highly":[192],"active":[193],"acceptable":[196],"toxicity":[197],"carcinoma.":[205]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}